Familial Hypercholesterolemia Clinical Trial
Official title:
Pilot Study for a National Screening for Familial Hypercholesterolemia
A pilot study to study the feasibility of the screening of familial hypercholesterolemia within the setting of the legal medical visits at primary school. The pilot study shall evaluate whether this screening set-up is efficient to detect patients having familial hypercholesterolemia, detect further patients by an adjacent cascade screening of family members, to deliver treatment to these patients and to provide this screening in a cost-effective manner.
Pilot study evaluating the feasibility of a screening for familial hypercholesterolemia. Cross-sectional design. Primary outcome Percentage of screened school children with confirmed familial hypercholesterolemia Participants All children, who attend a public primary school in the city of Luxembourg and are enrolled in the cycle C2.2 (age of 7-8 years; 3rd medical visit at school), cycle C3.2 (age 9-10 years, 4th medical visit at school) and cycle 4.2 (age 11-12 years, 5th medical visit at school) will be invited to participate. Expected number of invited children is around 1600 children/year. Recruitment will take place during the school year 2021/2022 and 2022/2023. The parents/caregivers of these children will receive written information about the screening. They will receive as well a questionnaire on the family history of premature cardiovascular events and known FHC disease. Without informed consent, the child cannot be included in the screening program. All children with signed informed consent will have a finger prick for a capillary blood test in the setting of their medical school exam by an external study nurse (not the school nurse) All data (pseudonymised) on each participant will be entered in the online data base for further analysis. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT05284513 -
Collaborative Approach to Reach Everyone With Familial Hypercholesterolemia (CARE-FH)
|
N/A | |
| Completed |
NCT02750527 -
Pediatric Population Screening for Type 1 Diabetes and Familial Hypercholesterolemia in Lower Saxony, Germany
|
||
| Not yet recruiting |
NCT00924339 -
Soy Food Intervention Trial
|
N/A | |
| Withdrawn |
NCT00751608 -
Effect of APL180 on Endothelial Function in Familial Hypercholesterolemia Patients
|
Phase 2 | |
| Terminated |
NCT00079846 -
Implitapide in Patients With Homozygous Familial Hypercholesterolemia (HoFH) on Maximal Concurrent Lipid-Lowering Therapy
|
Phase 2 | |
| Completed |
NCT02624869 -
Safety, Tolerability and Efficacy of Evolocumab (AMG 145) in Children With Inherited Elevated Low-density Lipoprotein Cholesterol (Familial Hypercholesterolemia)
|
Phase 3 | |
| Recruiting |
NCT05758779 -
The Danish Familial Hypercholesterolemia Organized Coronary Screening Trial
|
N/A | |
| Enrolling by invitation |
NCT04929457 -
Evaluation of a Digiphysical Screening Method to Identify and Diagnose Familial Hypercholesterolemia
|
||
| Not yet recruiting |
NCT04455581 -
A Study to Determine the Safety, Tolerability, and Efficacy of SHR-1209 in Patients With Familial Hypercholesterolemia
|
Phase 2 | |
| Recruiting |
NCT04101149 -
Genetic Causes of Familial Hypercholesterolemia
|
||
| Completed |
NCT00943306 -
Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia
|
Phase 3 | |
| Completed |
NCT02462655 -
Effects of LDL Apheresis System on the Expression of Genes Involved in Lipoprotein Metabolism and Inflammation in Homozygotes for Familial Hypercholesterolemia
|
N/A | |
| Terminated |
NCT00079859 -
Implitapide in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) on Maximal Concurrent Lipid-Lowering Therapy
|
Phase 2 | |
| Recruiting |
NCT05066932 -
Advanced Lipoproptein Profiling and Cardiovascular Risk Stratification in Familial Hypercholesterolemia
|
||
| Not yet recruiting |
NCT04958629 -
A Prospective Cohort Study on Familial Hypercholesterolemia in Health Examination Population
|
||
| Completed |
NCT02709850 -
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS ANGPTL3-LRx in Healthy Volunteers With Elevated Triglycerides and Participants With Familial Hypercholesterolemia
|
Phase 1 | |
| Active, not recruiting |
NCT03832985 -
Pediatric Reporting of Adult-Onset Genomic Results
|
Early Phase 1 | |
| Terminated |
NCT02013713 -
French Observatory of Familial Hypercholesterolemia in Cardiology
|
||
| Recruiting |
NCT02009345 -
Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada
|
||
| Terminated |
NCT03331666 -
Impact of LDL-cholesterol Lowering on Platelet Activation
|
Phase 4 |